Predicting treatment outcomes in major depressive disorder using brain magnetic resonance imaging: a meta-analysis-Reference-Cited by-同舟云学术

Predicting treatment outcomes in major depressive disorder using brain magnetic resonance imaging: a meta-analysis

Published:2024-08-26 Issue: Volume: Page:
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Long Fenghua^ORCID,Chen Yufei,Zhang Qian,Li Qian,Wang Yaxuan,Wang Yitian,Li Haoran,Zhao Youjin,McNamara Robert K.,DelBello Melissa P.,Sweeney John A.,Gong Qiyong^ORCID,Li Fei^ORCID

Funder

Sichuan Provincial Department of Science and Technology | Sichuan Province Science and Technology Support Program

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41380-024-02710-6.pdf

Reference108 articles.

1. World Health Organization. Depression fact sheet. World Health Organization. Published December 2019. Accessed November 20, 2022. https://www.who.int/mediacentre/factsheets/fs369/en/.

2. Chen X, Lu B, Li HX, Li XY, Wang YW, Castellanos FX, et al. The DIRECT consortium and the REST-meta-MDD project: towards neuroimaging biomarkers of major depressive disorder. Psychoradiology. 2022;2:32–42.

3. Jain FA, Connolly CG, Reus VI, Meyerhoff DJ, Yang TT, Mellon SH, et al. Cortisol, moderated by age, is associated with antidepressant treatment outcome and memory improvement in Major Depressive Disorder: A retrospective analysis. Psychoneuroendocrinology. 2019;109:104386.

4. Sramek JJ, Murphy MF, Cutler NR. Sex differences in the psychopharmacological treatment of depression. Dialogues Clin Neurosci. 2016;18:447–57.

5. Riedel M, Möller HJ, Obermeier M, Adli M, Bauer M, Kronmüller K, et al. Clinical predictors of response and remission in inpatients with depressive syndromes. J Affect Disord. 2011;133:137–49.